Explore 3 Stock Ideas & Industry Insights Download Free Report

Big Pharma Split Corp Class A

Company price
15.16 CAD -0.37 ( 2.38%)
Last update at 2026-11-04T14:37:00Z
VOLUME
478
Market Cap
16.83M

Momentum Score

…

Big Pharma Split Corp is a closed ended equity mutual fund launched and managed by Harvest Portfolios Group Inc. It invests in the public equity markets across United States. The fund primarily invests in the Pharmaceutical sector. Big Pharma Split Corp was formed on September 15, 2017 and is domiciled in Canada.

Source: TradingView
The charts and visual representations are sourced from TradingView through embedded widgets. For any issues with chart display, please visit the TradingView website

Day Price Range
14.32
Low
15.16
High
52 Week Price Range
9.88
Low
15.39
High

Momentum Score

…
Loading momentum score…

A unique technical analysis driven score developed by Kalkine showing momentum in stock prices based on select technical indicators identified.

Score - Rating
>= 1 - Low / > 1 but < 2 - Below Average / > 2 but < 3 - Average / > 3 but < 4 - Above Average / > 4 - High
AI Summary

Big Pharma Split Corp. (PRM.TO) is a Canadian split-share corporation that provides investors with exposure to a portfolio of large pharmaceutical equities by separating ownership into different share classes. Long-term growth drivers include demographic-driven demand and ongoing pharmaceutical innovation; investors may find the vehicle attractive for concentrated sector exposure and potential income or capital participation tied to the share class.
Main risks are concentrated sector exposure, regulatory and patent outcomes for underlying drugs, distribution sustainability and leverage inherent in split-share structures, plus market and currency volatility.

Risk Score
Medium

Note: The summary and risk score provided above is created by AI and should not be construed as a recommendation of Kalkine.

Key Metrics*

Previous Close
15.53
Dividend Yield
8.68%
Revenue TTM
5.11M
Revenue Per Share
4.17
Gross Profit TTM
5.11M
Debt / Equity
0.72
ROE
27.55%
Net Debt
11.82M
ROCE
27.38%
Diluted EPS TTM
-1.95

Key Financials*

Income Statement

Balance Sheet

Change in Cash

Total Operating Cash

Dividends Paid

Breakdown 2025-12-31 2024-12-31 2023-12-31 2022-12-31 2021-12-31
Type yearly yearly yearly yearly yearly
Date 2025-12-31 2024-12-31 2023-12-31 2022-12-31 2021-12-31
Income before tax 4.40M -0.54M -0.65M 3.15M 4.85M
Net income 4.40M -0.54M -0.14M 3.15M 4.85M
Selling general administrative 0.75M 0.54M 0.33M 0.36M 0.37M
Gross profit 1.14M 1.53M 0.31M 3.71M 5.36M
Ebit - - -0.50M - 4.61M
Ebitda 5.03M 0.02M -0.14M 3.15M 4.85M
Depreciation and amortization - - 0.36M - -
Operating income 5.03M 0.01M -0.14M 3.15M 4.85M
Other operating expenses 3.58M 1.84M 0.45M 0.57M 0.51M
Interest expense 0.64M 0.56M 0.51M - 0.00M
Income tax expense - - -0.51M - -
Total revenue 1.45M 1.85M 0.31M 3.71M 5.36M
Total operating expenses -3.89M 0.54M 0.45M 0.57M 0.51M
Cost of revenue 0.31M 0.32M 0.31M - -
Total other income expense net -0.63M -0.55M -0.51M - -
Net income from continuing ops - 0.01M -0.14M 3.15M 4.85M
Net income applicable to common shares 4.40M -0.54M -0.65M - 4.21M
Breakdown 2025-12-31 2024-12-31 2023-12-31 2022-12-31 2021-12-31
Type yearly yearly yearly yearly yearly
Date 2025-12-31 2024-12-31 2023-12-31 2022-12-31 2021-12-31
Total assets 31.84M 26.30M 26.53M 39.10M 37.81M
Other current assets - -26.30M 0.72M - 0.81M
Total liab 13.57M 12.62M 0.25M 19.37M 15.41M
Total stockholder equity 18.27M 13.68M 15.85M 19.73M 22.40M
Other current liab 0.30M -11.57M -0.25M -0.35M -0.34M
Common stock 18.27M - 15.85M - 22.40M
Other assets - 26.30M - - 0.15M
Cash 1.35M 1.03M 0.20M 0.82M 1.43M
Total current liabilities 13.47M - 0.25M 0.35M 0.34M
Current deferred revenue - - -10.05M - -
Net debt 11.82M 10.54M 10.09M -0.82M -1.43M
Short term debt 13.17M 11.57M 10.30M - -
Short long term debt total 13.17M 11.57M 10.30M - -
Other stockholder equity 18.27M 13.68M - - 22.40M
Total current assets 31.33M - 0.28M 14.82M 1.53M
Long term investments - - 26.25M 24.27M 36.13M
Net tangible assets - - - - 22.40M
Short term investments 29.87M 25.17M 25.54M - -
Net receivables 0.11M 0.10M 0.08M 14.00M 0.10M
Inventory - - -0.72M - -
Accounts payable - - 0.25M 0.35M 0.34M
Non currrent assets other - - -26.25M -24.27M -36.13M
Non current assets total 0.51M - 26.25M 24.27M 36.13M
Long term debt total 0.00M - - - -
Breakdown 2025-12-31 2024-12-31 2023-12-31 2022-12-31 2021-12-31
Type yearly yearly yearly yearly yearly
Date 2025-12-31 2024-12-31 2023-12-31 2022-12-31 2021-12-31
Change to liabilities - - - - 0.00M
Total cash from financing activities 1.81M -0.35M -12.47M -1.74M 10.19M
Change to operating activities - - - - -0.15M
Net income 4.40M -0.54M -0.65M 2.39M 4.21M
Change in cash 0.32M 0.83M -0.62M -0.61M 1.20M
Begin period cash flow 1.03M 0.20M 0.82M 1.43M 0.23M
End period cash flow 1.35M 1.03M 0.20M 0.82M 1.43M
Total cash from operating activities -1.06M -1.30M 11.86M 1.13M -9.00M
Issuance of capital stock - 1.95M 0.45M 0.88M 13.32M
Other cashflows from investing activities - - 0.00M - -
Dividends paid 1.51M -1.50M -2.11M 2.62M 2.84M
Sale purchase of stock 3.34M -0.47M -5.32M - -
Other cashflows from financing activities -0.03M -0.01M -4.60M 0.48M 5.46M
Change to netincome - - - - -13.06M
Capital expenditures 0.00M 0.00M 0.00M 0.00M 0.00M
Change in working capital -0.03M -0.01M 0.01M 0.18M -0.15M
Other non cash items -5.42M -0.74M 12.49M -1.44M -13.06M
Free cash flow -1.06M -1.30M 11.86M 1.13M -9.00M

Peer Comparison*

Sector: Financial Services Industry: Asset Management

Stock Name
Change
(CAD)
Price
(CAD)
Trailing
PE (x)
Forward
PE (x)
Price Sales
TTM (x)
Price to Book Value (x)
Enterprise Value
to Revenue (x)
Enterprise Value
to EBITDA (x)
PRM
Big Pharma Split Corp Class A
-0.37
2.38%
15.16 - - 6.28 1.07 6.67 -2.45
BLK
BlackRock CDR (CAD Hedged)
1.70
5.77%
31.14 25.23 18.90 6.38 2.79 6.35 17.13
BN
Brookfield Corporation
3.35
5.89%
60.20 94.76 11.96 1.84 2.36 4.58 10.80
BAM
Brookfield Asset Management Ltd
4.01
5.62%
75.33 31.22 25.51 22.40 9.70 17.61 25.08
PHYS
Sprott Physical Gold Trust
1.14
2.74%
42.73 3.81 - 3.47 1.06 4.09 0.66

Profile*

Big Pharma Split Corp Class A

Big Pharma Split Corp is a closed ended equity mutual fund launched and managed by Harvest Portfolios Group Inc. It invests in the public equity markets across United States. The fund primarily invests in the Pharmaceutical sector. Big Pharma Split Corp was formed on September 15, 2017 and is domiciled in Canada.

610 Chartwell Road, Oakville, ON, Canada, L6j 4A5

416-649-4541

Disclaimer - (*)This information, including any data, is sourced from Unicorn Data Services SAS, trading as EOD Historical Data (“EODHD”) on an ‘as is’ basis, using their API. We cannot guarantee the completeness or validity of the information and data provided on this page, as well as via the API. In some cases, the data may include analyst ratings or recommendations sourced through the EODHD API, which are intended solely for general information purposes.
This information does not consider your personal objectives, financial situation, or needs. Kalkine is not liable for any errors or omissions in the information provided or for any actions taken in reliance on it. You should seek advice from a financial adviser, stockbroker or other professional adviser (including taxation and legal advice) as necessary before acting on this information.

Support

Hi! How can we help you today?

Loading…